Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer Trajectory.
Anxiety
Breast cancer
Depression
Fatigue
Pain
Journal
International journal of behavioral medicine
ISSN: 1532-7558
Titre abrégé: Int J Behav Med
Pays: England
ID NLM: 9421097
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
07
07
2022
medline:
3
7
2023
pubmed:
14
7
2022
entrez:
13
7
2022
Statut:
ppublish
Résumé
Psychological disorders can substantially worsen physical symptoms associated with breast cancer diagnosis and treatment, reducing survivors' quality of life and increasing recurrence risk. Distress disorders may be particularly detrimental given their physical correlates. Across two studies, we examined the relationship between a distress disorder history and physical symptoms pre- and post-adjuvant treatment - two important periods of the cancer trajectory. Breast cancer patients awaiting adjuvant treatment (n = 147; mean age = 52.54) in study 1 and survivors 1-10 years post-treatment (n = 183; mean age = 56.11) in study 2 completed a diagnostic interview assessing lifetime presence of psychological disorders. They also rated their pain, fatigue, physical functioning, and self-rated health. Covariates included body mass index, age, cancer stage, menopause status, and physical comorbidities. Results from both studies indicated that a distress disorder history was associated with higher pain, fatigue, and sleep difficulties as well as lower self-rated health compared to those without such a history. These findings suggest that breast cancer survivors with a distress disorder may be particularly at risk for more physical symptoms, poorer sleep, and worse self-rated health both prior to and following adjuvant treatment.
Sections du résumé
BACKGROUND
BACKGROUND
Psychological disorders can substantially worsen physical symptoms associated with breast cancer diagnosis and treatment, reducing survivors' quality of life and increasing recurrence risk. Distress disorders may be particularly detrimental given their physical correlates. Across two studies, we examined the relationship between a distress disorder history and physical symptoms pre- and post-adjuvant treatment - two important periods of the cancer trajectory.
METHODS
METHODS
Breast cancer patients awaiting adjuvant treatment (n = 147; mean age = 52.54) in study 1 and survivors 1-10 years post-treatment (n = 183; mean age = 56.11) in study 2 completed a diagnostic interview assessing lifetime presence of psychological disorders. They also rated their pain, fatigue, physical functioning, and self-rated health. Covariates included body mass index, age, cancer stage, menopause status, and physical comorbidities.
RESULTS
RESULTS
Results from both studies indicated that a distress disorder history was associated with higher pain, fatigue, and sleep difficulties as well as lower self-rated health compared to those without such a history.
CONCLUSIONS
CONCLUSIONS
These findings suggest that breast cancer survivors with a distress disorder may be particularly at risk for more physical symptoms, poorer sleep, and worse self-rated health both prior to and following adjuvant treatment.
Identifiants
pubmed: 35831698
doi: 10.1007/s12529-022-10115-4
pii: 10.1007/s12529-022-10115-4
pmc: PMC10278051
mid: NIHMS1904620
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
463-472Subventions
Organisme : NCI NIH HHS
ID : R01 CA186720
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002735
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA186251
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA229114
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA186720
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA186251
Pays : United States
Organisme : NIH HHS
ID : TL1TR002735
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM115428
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA186720
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA186251
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA229114
Pays : United States
Organisme : NIH HHS
ID : TL1TR002735
Pays : United States
Informations de copyright
© 2022. International Society of Behavioral Medicine.
Références
Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J Abnorm Psychol. 2005;114(4):522–36.
pubmed: 16351375
doi: 10.1037/0021-843X.114.4.522
Tyrer P, Baldwin D. Generalised anxiety disorder. The Lancet. 2006;368(9553):2156–66.
doi: 10.1016/S0140-6736(06)69865-6
Hare DL, et al. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365–72.
pubmed: 24282187
doi: 10.1093/eurheartj/eht462
Cohen BE, Edmondson D, Kronish IM. State of the art review: depression, stress, anxiety, and cardiovascular disease. Am J Hypertens. 2015;28(11):1295–302.
pubmed: 25911639
pmcid: 4612342
doi: 10.1093/ajh/hpv047
Niedzwiedz CL, et al. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19(1):1–8.
doi: 10.1186/s12885-019-6181-4
Mehnert A, et al. One in two cancer patients is significantly distressed: prevalence and indicators of distress. Psychooncology. 2018;27(1):75–82.
pubmed: 28568377
doi: 10.1002/pon.4464
Syrowatka A, et al. Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat. 2017;165(2):229–45.
pubmed: 28553684
pmcid: 5543195
doi: 10.1007/s10549-017-4290-9
Carreira H, et al. Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. JNCI: J Nat Cancer Ins. 2018;110(12):1311–1327.
Pilevarzadeh M, et al. Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;176(3):519–33.
pubmed: 31087199
doi: 10.1007/s10549-019-05271-3
Fatiregun OA, et al. Anxiety disorders in breast cancer: prevalence, types, and determinants. 2016;34(5):32–447.
Administration S.A.a.M.H.S. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health. 2020.
O’Connor M, et al. How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer. Br J Cancer. 2011;104(3):419.
pubmed: 21224851
pmcid: 3049569
doi: 10.1038/sj.bjc.6606073
Bleiker EM, et al. Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient Educ Couns. 2000;40(3):209–17.
pubmed: 10838000
doi: 10.1016/S0738-3991(99)00085-3
Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. Journal of Gerontology: Medical Sciences. 2003;58:82–91.
Sheridan D, et al. Long-term follow-up of pain and emotional characteristics of women after surgery for breast cancer. J Pain Symptom Manage. 2012;44(4):608–14.
pubmed: 22743155
doi: 10.1016/j.jpainsymman.2011.10.021
Laird BJ, et al. Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage. 2011;42(1):1–11.
pubmed: 21402467
doi: 10.1016/j.jpainsymman.2010.10.261
Savard J, et al. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24(5):583–90.
pubmed: 11480655
doi: 10.1093/sleep/24.5.583
Bower JE, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106(4):751–8.
pubmed: 16400678
doi: 10.1002/cncr.21671
Hagen KB, et al. Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls. The Breast. 2016;28:100–6.
pubmed: 27262826
doi: 10.1016/j.breast.2016.05.005
Bower JE, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–743.
pubmed: 10673515
doi: 10.1200/JCO.2000.18.4.743
Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2010;45(3):355–61.
pubmed: 19458878
doi: 10.1007/s00127-009-0068-7
Curt GA, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist. 2000;5(5):353–60.
pubmed: 11040270
doi: 10.1634/theoncologist.5-5-353
Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev. 2007;27(8):959–85.
pubmed: 17448579
pmcid: 2169519
doi: 10.1016/j.cpr.2007.02.005
Wichers M, et al. Scars in depression: is a conceptual shift necessary to solve the puzzle? Psychol Med. 2010;40(3):359–65.
pubmed: 20120516
doi: 10.1017/S0033291709990420
Gunthert KC, et al. Depression and next-day spillover of negative mood and depressive cognitions following interpersonal stress. Cogn Ther Res. 2007;31(4):521–32.
doi: 10.1007/s10608-006-9074-1
Husky MM, et al. Past depression and gender interact to influence emotional reactivity to daily life stress. Cogn Ther Res. 2009;33(3):264–71.
doi: 10.1007/s10608-008-9212-z
Jim HS, et al. History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer. Ann Behav Med. 2012;43(3):402–8.
pubmed: 22167580
doi: 10.1007/s12160-011-9333-6
Jensen LS, et al. The impact of prior psychiatric medical treatment on return to work after a diagnosis of breast cancer: a registry based study. Scandinavian journal of public health. 2019;47(5):519–27.
pubmed: 28789594
doi: 10.1177/1403494817722291
First MB, et al. Structured clinical interview for DSM-V axis I disorders, research version, patient edition. 2015: Arlington, VA.
Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33(5):350–7.
pubmed: 11491194
doi: 10.3109/07853890109002089
Stanton AL, Bernaards CA, Ganz PA. The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst. 2005;97(6):448–56.
pubmed: 15770009
doi: 10.1093/jnci/dji069
Fu MR, et al. Comorbidities and quality of life among breast cancer survivors: a prospective study. Journal of personalized medicine. 2015;5(3):229–42.
pubmed: 26132751
pmcid: 4600145
doi: 10.3390/jpm5030229
Partridge AH, Burstein HJ, Winer EP. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. JNCI Monographs. 2001;2001(30):135–42.
doi: 10.1093/oxfordjournals.jncimonographs.a003451
Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
pubmed: 3558716
doi: 10.1016/0021-9681(87)90171-8
McFarland DC, et al. Physical symptom burden and its association with distress, anxiety, and depression in breast cancer. Psychosomatics. 2018;59(5):464–71.
pubmed: 29525522
pmcid: 6067989
doi: 10.1016/j.psym.2018.01.005
Kurtz ME, et al. Physical functioning and depression among older persons with cancer. Cancer Pract. 2001;9(1):11–8.
pubmed: 11879268
doi: 10.1046/j.1523-5394.2001.91004.x
Faller H, et al. Symptoms of depression and anxiety as predictors of physical functioning in breast cancer patients. A prospective study using path analysis. Acta Oncologica, 2017;56(12):1677–1681.
Renna ME, et al. Worry and rumination in breast cancer patients: perseveration worsens self-rated health. J Behav Med. 2021;44(2):253–9.
pubmed: 33135103
doi: 10.1007/s10865-020-00192-9
Renna ME, et al. Within-person changes in cancer-related distress predict breast cancer survivors’ inflammation across treatment. Psychoneuroendocrinology. 2020;121: 104866.
pubmed: 32947247
pmcid: 7572735
doi: 10.1016/j.psyneuen.2020.104866
Clancy F, et al. Perseverative cognition and health behaviors: a systematic review and meta-analysis. Front Hum Neurosci. 2016;10:534.
pubmed: 27877119
pmcid: 5099163
doi: 10.3389/fnhum.2016.00534
Strine TW, et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry. 2008;30(2):127–37.
pubmed: 18291294
doi: 10.1016/j.genhosppsych.2007.12.008
Doyle C, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA: A Cancer Journal for Clinicians. 2006;56(6):323–353.
Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med. 2006;29(1):17–27.
pubmed: 16400532
doi: 10.1007/s10865-005-9036-1
Cramer H, et al. Mindfulness-based stress reduction for breast cancer—a systematic review and meta-analysis. Curr Oncol. 2012;19(5): e343.
pubmed: 23144582
pmcid: 3457885
doi: 10.3747/co.19.1016
Kiecolt-Glaser JK, et al. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32(10):1040.
pubmed: 24470004
pmcid: 3965259
doi: 10.1200/JCO.2013.51.8860
Rankin NM, et al. Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for anxiety and depression in cancer. BMC Health Serv Res. 2015;15(1):1–8.
doi: 10.1186/s12913-015-0691-9
CoC. Optimal Resources for Cancer Care (2020 Standards). 2019 [cited 2020 04/24/2020]; Available from: https://www.facs.org/-/media/files/quality-programs/cancer/coc/optimal_resources_for_cancer_care_2020_standards.ashx .
Andersen BL, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605–19.
pubmed: 24733793
pmcid: 4090422
doi: 10.1200/JCO.2013.52.4611